`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`APOTEX INC.
`Petitioner,
`
`v.
`
`UCB BIOPHARMA SPRL,
`Patent Owner.
`______________
`
`Case IPR2019-00400
`Patent 8,633,194
`______________
`
`
`PATENT OWNER’S MOTION TO SEAL PURSUANT TO 37 C.F.R. § 42.54
`
`
`
`
`
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`Patent Owner UCB Biopharma Sprl hereby moves to seal Attachment A to
`
`the Parties’ Joint Stipulation Regarding the Deposition of Domenico Fanara (filed
`
`available to everyone as Paper No. 26, and filed available to Board and parties as
`
`Paper No. 27), which contains Patent Owner’s confidential information. In
`
`connection with that Stipulation, Patent Owner has filed a redacted, non-confidential
`
`version of Attachment A (identified as “Attachment B” to the Joint Stipulation).
`
`On July 30, 2019, Patent Owner submitted an unopposed Motion to Seal and
`
`for Entry of a Protective Order Pursuant to 37 C.F.R. § 42.54 (Paper No. 18), which
`
`remains pending in this proceeding. Accordingly, Patent Owner has proceeded
`
`under the guidelines of the pending Protective Order.
`
`Patent Owner and Petitioner have discussed this Motion, and Petitioner does
`
`not oppose this Motion.
`
`I. MOTION TO SEAL
`
`Patent Owner moves to seal Attachment A to the Parties’ Joint Stipulation
`
`Regarding the Deposition of Domenico Fanara (Paper No. 26). Attachment A is an
`
`excerpted version of the deposition of inventor Domenico Fanara which was taken
`
`in the related district court litigation (UCB, Inc. et al. v. Apotex Inc., No. 0-18-cv-
`
`60846 (S.D. Fla.)). That deposition was marked “highly confidential” under the
`
`protective order of that case. See UCB, Inc. et al. v. Apotex Inc., ECF Nos. 34 and
`
`38.
`
`
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`Excerpted portions of deposition testimony now submitted in Attachment A
`
`to the Parties’ Joint Stipulation discloses certain confidential information subject to
`
`the district court protective order. Specifically, the deposition testimony contains
`
`(1) information relating to a strategic partnership with a pharmaceutical company
`
`not party to this proceeding and (2) details regarding Patent Owner’s pharmaceutical
`
`formulations. None of the confidential information has previously been made
`
`public.
`
`The standard for granting a motion to seal is “for good cause.” 37 C.F.R.
`
`§ 42.54. Good cause exists here because the nature of the relationship between
`
`Patent Owner and the third-party pharmaceutical company, and the specifications
`
`for Patent Owner’s pharmaceutical formulations are competitively-sensitive, non-
`
`public, business information. See, e.g. Westinghouse Air Brake Techs. Corp. v.
`
`Siemens Mobility, Inc., IPR2017-01669, Paper 60 (PTAB Jan. 8, 2019) (granting
`
`motion to seal similar information). The information further does not relate to the
`
`patentability of claims in an issued patent or otherwise affect the rights of the public.
`
`Further, as reflected in the redacted version of Attachment A that Patent Owner has
`
`submitted with the Parties’ Joint Stipulation (Attachment B), the proposed
`
`redactions are minimal.
`
`II. CONCLUSION
`
`For the foregoing reasons, Patent Owner respectfully requests that the Board
`
`-2-
`
`
`
`grant this motion to seal.
`
`
`
`Dated: November 26, 2019
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`Respectfully submitted,
`
`/Robert E. Counihan/ (Electronically signed)
`James S. Trainor, Reg. No. 52,297
`Lead Counsel
`
`Robert E. Counihan, Reg. No. 61,382
`Back-Up Counsel
`
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`(212) 430-2600
`jtrainor@fenwick.com
`rcounihan@fenwick.com
`
`Erica R. Sutter, Reg. No. 77,450
`801 California Street
`Mountain View, CA 94041
`(650) 988-8500
`esutter@fenwick.com
`
`
`Counsel for Patent Owner UCB Biopharma
`Sprl
`
`
`
`
`
`-3-
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on November 26, 2019, the
`
`foregoing document is being served by filing this document through the Patent Trial and
`
`Appeal Board End to End System, as well as by delivering a copy via electronic mail
`
`upon the following counsel of record for the Petitioner:
`
`jitty.malik@kattenlaw.com
`alissa.pacchioli@kattenlaw.com
`joe.janusz@kattenlaw.com
`lance.soderstrom@kattenlaw.com
`
`
`Date: November 26, 2019
`
`
`
`
`Respectfully submitted,
`
`
`
`/Robert E. Counihan/ (Electronically signed)
`Robert E. Counihan
`Reg. No. 61,382
`Phone: (212) 430-2600
`
`-4-
`
`